| ||||
PROSTATE, LUNG, COLORECTAL & OVARIAN CANCER SCREENING TRIAL (PLCO)
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, or PLCO, is a large-scale clinical trial to determine whether certain cancer screening tests reduce deaths from prostate, lung, colorectal and ovarian cancer. In addition, there are numerous epidemiologic and ancillary studies going on that will answer other crucial questions about these cancers and these screening tests. More..>>> About the Participants and the Screening TestsMore than 154,000 women and men between the ages of 55 and 74 joined the trial between 1992 and 2001 at 10 centers across the country. Half of these participants were selected by chance to receive specific screening tests and half receive routine care by their personal health care providers. All participants provide regular updates on a variety of health measurements in an annual questionnaire, as well as blood samples for use in studies of biologic markers of cancer risk. More.>>>
|
|
|||||
HOME | DICTIONARY | SITE MAP | SEARCH |
||||||